Using a mHealth App to Improve Quality-of-Life Outcomes in Black Prostate Cancer Survivors
Launched by UNIVERSITY OF OKLAHOMA · Oct 17, 2024
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how a mobile health app can help improve the quality of life for Black men who are either currently receiving treatment for prostate cancer or who have survived it. The study aims to make sure the app is easy to use and acceptable for patients, gather their feedback to enhance it, and evaluate how well it supports their well-being during their cancer journey.
To participate, you need to be a Black man who has been diagnosed with prostate cancer within the last five years. This includes those born in the U.S., the Caribbean, or Africa. Unfortunately, those who are not Black, have never had prostate cancer, cannot speak English, do not own a smartphone, or are more than five years post-diagnosis are not eligible. If you join the study, you can expect to provide your thoughts on the app and help shape its future use, contributing to better support for other survivors like yourself.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • - Ethnically-diverse Black prostate cancer (CaP) survivors who are either native-born, Caribbean-born, or African-born, within the early phase of their CaP survivorship journey (defined as within the first five years after diagnosis).
- Exclusion Criteria:
- • Men from other races.
- • Men who have never been diagnosed with CaP
- • Men who have the inability to speak English
- • Men who do not own a smartphone
- • Black CaP survivors who are over 5 years since the time of diagnosis
About University Of Oklahoma
The University of Oklahoma, a leading research institution, is dedicated to advancing healthcare through innovative clinical trials and research initiatives. With a robust network of interdisciplinary experts and state-of-the-art facilities, the university fosters an environment that promotes scientific discovery and the development of new treatments. Its commitment to patient-centered research ensures that clinical trials not only adhere to the highest ethical standards but also aim to address pressing health challenges. By collaborating with various stakeholders, including industry partners and healthcare providers, the University of Oklahoma seeks to translate research findings into tangible benefits for communities, ultimately enhancing the quality of care and improving health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oklahoma City, Oklahoma, United States
Tallahassee, Florida, United States
Milledgeville, Georgia, United States
Patients applied
Trial Officials
Motolani Adedipe, PhD, DPh, MS
Principal Investigator
University of Oklahoma
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported